Back to Journals

Neuropsychiatric Disease and Treatment

ISSN: 1178-2021

Dr Roger Pinder

Dr Pinder

Pharma, Independent Pharma Consultant, York, UK

Roger M. Pinder, PhD, DSc is an independent pharma consultant based in the city of York in the UK. He advises and consults worldwide to several pharmaceutical and venture capital organizations. He is founding editor of Neuropsychiatric Disease and Treatment and of the International Journal of Wine Research. He has served as president and secretary of the International Society for Affective Disorders (ISAD), and as treasurer and councillor of the International College of Neuropsychopharmacology (CINP).

Educated in the UK and the USA at the universities of Hull and Virginia, Dr Pinder holds doctoral degrees in medicinal chemistry (PhD) and neuropsychopharmacology (DSc). He is a fellow of the British Pharmacological Society, the British Association for Psychopharmacology, the European (ECNP) and the International Colleges of Neuropsychopharmacology (CINP), and of ISAD. His professional research interests include cardiovascular and CNS pharmacology and therapeutics, with a special emphasis on depressive disorders, anti-depressants and the health benefits of wine. He is a regular speaker and chair at international congresses, and has published five books and more than 250 review and research articles.

After a long career in R&D and medical affairs management in the international pharmaceutical industry, Dr Pinder was associated with a number of start-up pharmaceutical companies as chairman, board member, advisor and consultant.

Dr Jun Chen

Dr Chen

Clinical Research Center, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China

Dr. Jun Chen is the director of the office for Clinical Research Center, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine (SMHC). He is serving as a Board Member/Asia for the International Society for Bipolar Disorders (ISBD), Fellow for the Pacific Rim College of Psychiatrists (PRCP), Secretary for the Chinese Society of Psychiatry (CSP), Vice Chairman for the Youth Committee of the CSP, and Committee member for the Chinese Psychiatrist Association (CPA).

Educated in China and USA, he received his M.D./Ph.D. degree in psychiatry at Shanghai Jiao Tong University School of Medicine in 2009. In 2010, he got the early-career psychiatrist research fellow funding from the World Psychiatric Association. After that, he worked and studied with Prof. Joseph R. Calabrese and Dr. Keming Gao in the Mood Disorders Program in Case Western Reserve University School of Medicine for one year. From 2014, Dr. Chen joined the APEC workshop to promote innovative collaborations in mental health, to work together with professionals from APEC.

Dr. Chen's research focuses on the phenomenon and treatment of bipolar disorder and treatment-resistant depression, which including clinical trial, cognition function and neuroimaging.

Dr Taro Kishi

Dr Kishi

Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Japan

Dr. Kishi has been practicing at the Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Japan, since 2002. In 2010 and 2011, he spent two years as a postdoctoral research fellow at the Zucker Hillside Hospital in New York. Dr. Kishi is a senior lecturer at the Department of Psychiatry, Fujita Health University School of Medicine. Dr. Kishi has been performing a series of clinical trials for the treatment of schizophrenia and mood disorder. His research focus is also evidence-based medicine in schizophrenia and mood disorder with a focus on meta-analyses. Moreover, he has a research interest in psychiatric genetics, pharmacogenetics, compliance enhancement strategies and medical decision making. He has authored/co-authored more than 120 articles.

Dr Rakesh Kumar

Dr Kumar

Department of Psychiatry & Psychology, Mayo Clinic, Rochester, MN, USA

Dr. Rakesh Kumar is a Fellow at the Mayo Clinic. He completed medical school at Goa Medical College, India, and gained a Mood fellowship at Mayo Clinic. He completed a M.D. Psychiatry Residency in India. He is a recipient of the Junior Colloquium Award from the American Psychiatric Association and a New Investigator Award from the American Society of Clinical Psychopharmacology. He is a member of the ASCP, CTMS, and NNDC. He is interested in the intervention psychiatry, neurobiology, and neuroimaging of mood disorders, novel treatments for mood disorders-especially NIBS- TMS, ketamine, and DBS -and investigating biomarkers to facilitate individualized treatment for treatment-resistant depression and Bipolar Disorder.

Dr Yuping Ning

Dr Ning

Department of Psychiatry, Mental Health Institute of the Second Xiangya Hospital, Central South University, Guangzhou, China

Dr. Yuping Ning is director of the affiliated brain hospital of Guangzhou Medical University P.R.C. She is professor in neuropsychiatry and supervisor of PH.D students. She holds some positions such as member of Chinese Society of Psychiatry, Chairman of Guangdong Society of Psychiatry, member of standing committee of Guangdong Society of Neurology, etc. From 1986 to 1992, she educated in XiangYa Medical college and got MD degree there. From 1992 to 1997, she practiced psychiatry in Guangzhou Brain Hospital. From 1997 to 2003, she practiced and pursued her PHD in department of Neurology, Sun Yat-Sen medical university. Her research interests are in neurodegenerative diseases (AD and PD) and depression. As a visiting scholar, she performed genetic study in Parkinson disease in Juntendo University Japan. She has published 130 papers so far.

Editorial Board

Hojjat Adeli is an Academy Professor at The Ohio State University. He is the recipient of eight Honorary Doctorates and elected into five European Academies. He is the co-author of 16 ground-breaking books including: Automated EEG-based Diagnosis of Neurological Disorders - Inventing the Future of Neurology (CRC Press 2010), USA.

Kristian Barlinn, Department of Neurology, University Hospital Carl Gustav Carus, Dresden, Germany

Marlene Oscar Berman, Professor Emerita at BUSM, Professor of Psychiatry, Neurology, Anatomy and Neurobiology, Boston University School of Medicine, Boston, Massachusetts, USA, Dr. Berman also is a Research Scientist at the Department of Veterans Affairs Healthcare facility in Boston.

Francesca Bisulli, MD PhD, Associate Professor, University of Bologna, Italy, Assistant Medical Director, IRCCS Istituto delle Scienze Neurologiche, Bologna, Italy

Tindara Capri, Professor, Department of Life and Health Sciences, Link Campus University, Via del Casale di S. Pio V, 44, 00165, Rome, Italy.

Sandra Chan, Professor, Department of Psychiatry, The Chinese University of Hong Kong, Hong Kong

Lin Chen, MD, Ph.D., Neurosurgeon, Department of Neurosurgery, Tsinghua University Yuquan Hospital, People’s Republic of China

Wai-Tong Chien, Professor, Nethersole School of Nursing, Faculty of Medicine, The Chinese University of Hong Kong.

Dr Francesco Craig, PhD - Child and Adolescent Neuropsychiatry, Department of Culture, Education and Society - University of Calabria, Italy.

Alessandro Cuomo, MD-PhD,  Assistant Professor in Psychiatry, Division of Psychiatry, Department of Molecular Medicine, University of Siena School of Medicine, Italy

Professor Anthony S. David, Director, Institute of Mental Health, University College London, UK.

Valsamma Eapen, Professor, Department and Faculty Head, School of Psychiatry, University of New South Wales, Australia. 

Andrea Fagiolini, Professor of Psychiatry, Chairman, Department of Molecular Medicine, University of Siena, Italy

Mike Isaac, Honorary Consultant and Hon Senior Lecturer in Psychiatry, South London & Maudsley NHS FT and University of London, UK

Andrey Iznak, Professor, Mental Health Research Centre, Moscow, Russia

Sidney H Kennedy, Professor and Arthur Sommer Rotenberg Chair in Depression and Suicide Studies, St. Michael’s Hospital and University of Toronto, Executive Director, Homewood Research Institute, Guelph, Ontario, Canada.

Firas H Kobeissy, Professor, Department of Neuroscience, Morehouse School of Medicine, Atlanta, Georgia, USA

Michael Krausz, UBC-Providence Leadership Chair for Addiction Research, Professor of Psychiatry, Director Addiction Psychiatry, Institute of Mental Health, The University of British Columbia, Vancouver, BC, Canada

John S Markowitz, Professor, Department of Pharmacotherapy and Translational Research, University of Florida College of Pharmacy, FL, USA

Peter R. Martin, M.D., Professor of Psychiatry and Behavioral Sciences, Professor of Pharmacology, Vanderbilt Psychiatric Hospital, Vanderbilt University School of Medicine, Nashville, TN, USA

Julien Mendlewicz, Professor, Free University of Brussels, Brussels, Belgium

Prof. Dr. Shinichi Mitsui, Department of Rehabilitation Sciences, Gunma University Graduate School of Health Sciences, Maebashi, Gunma, Japan

Zoran M Pavlovic MD, CEO, Heruka Lifescience & Health Innovations, Belgrade, Serbia.

Steven Potkin, Professor, University of California, Irvine, USA

Norman Sartorius, MD, PhD, FRCpsych, President, Association for the Improvement of Mental Health Programmes, Switzerland

Alessandro Serretti, MD, PhD, Department of Biomedical and NeuroMotor Sciences, University of Bologna, Italy

Timo Siepmann, Professor, PD Dr. med. habil, FAHA - Attending physician and director of the Telestroke Network Eastern Saxony (SOS TeleNET). He is also scientific director of the Master’s Program in Clinical Research at Dresden International University and Site Director of Dresden Site at Principles and Practice of Clinical Research, Harvard T.H. Chan School of Public Health. Professor Siepmann is an International Fellow of the American Heart Association, Germany

Edoardo Spina, Professor of Pharmacology, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.

Eduard Vieta, Professor and Director of Research, Clinical Institute of Neuroscience, Hospital Clinic, University of Barcelona, Spain

Ng Beng Yeong, Consultant Psychiatrist, Mount Elizabeth Medical Centre, Singapore

Nathan Zasler, CEO & Medical Director for Concussion Care Centre of Virginia, Ltd, Medical Director for Tree of Life Services, Inc.; Clinical Professor, Department of PM&R, Virginia Commonwealth University, and Clinical Associate Professor, Department of PM&R, University of Virginia, Charlottesville, Virginia, USA